Patent · US Active

Compounds

US8236827B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2009
Grant dateAug 7, 2012
Priority date—
Expiry dateMay 17, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound for use in the treatment of proliferative disorders, such as cancer, having the following formula:wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.